THEREMS - Trademark Details
Status: 800 - Registered And Renewed
Image for trademark with serial number 76006864
Serial Number
76006864
Registration Number
2465458
Word Mark
THEREMS
Status
800 - Registered And Renewed
Status Date
2021-10-02
Filing Date
2000-03-22
Registration Number
2465458
Registration Date
2001-07-03
Mark Drawing
1000 - Typeset: Word(s)/letter(s)/number(s) Typeset
Published for Opposition Date
2001-04-10
Attorney Name
N. Christopher Norton
Law Office Assigned Location Code
L50
Employee Name
CASE, LEIGH CAROLINE
Statements
Goods and Services
MULTIVITAMIN AND MINERAL SUPPLEMENTS
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2000-06-14
Primary Code
005
First Use Anywhere Date
1977-01-00
First Use In Commerce Date
1977-01-00
Current Trademark Owners
Party Name
THE HARVARD DRUG GROUP, L.L.C.
Party Type
31 - 1st New Owner Entered After Registration
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
THE HARVARD DRUG GROUP, L.L.C.
Party Type
31 - 1st New Owner Entered After Registration
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Watson Pharmaceuticals, Inc.
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Watson Pharmaceuticals, Inc.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Watson Pharmaceuticals, Inc.
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
N. Christopher Norton
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2000-08-24ASSIGNED TO EXAMINER
2000-09-01EXAMINER'S AMENDMENT MAILED
2000-09-22APPROVED FOR PUB - PRINCIPAL REGISTER
2001-03-28NOTICE OF PUBLICATION
2001-04-10PUBLISHED FOR OPPOSITION
2001-07-03REGISTERED-PRINCIPAL REGISTER
2006-10-06CASE FILE IN TICRS
2007-01-03TEAS CHANGE OF CORRESPONDENCE RECEIVED
2007-01-04TEAS CHANGE OF CORRESPONDENCE RECEIVED
2007-04-16TEAS SECTION 8 & 15 RECEIVED
2007-04-16REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
2007-05-15ASSIGNED TO PARALEGAL
2007-05-18REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
2010-09-20TEAS SECTION 8 & 9 RECEIVED
2010-09-21REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
2010-09-21REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
2012-11-07AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
2014-04-14TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2014-04-14ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2015-10-12TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2015-10-12ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2020-07-03COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
2021-03-30TEAS CHANGE OF OWNER ADDRESS RECEIVED
2021-03-30TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2021-03-30ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2021-03-30TEAS CHANGE OF CORRESPONDENCE RECEIVED
2021-03-30APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2021-05-27TEAS SECTION 8 & 9 RECEIVED
2021-10-02CASE ASSIGNED TO POST REGISTRATION PARALEGAL
2021-10-02REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
2021-10-02REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
2021-10-02NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED